Hilar cholangiocarcinoma
Conditions
Sponsors
Affiliated Hospital of North Sichuan Medical College
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.There is no restriction on the gender of men and women, Chinese citizens aged >=18 years old; 2.Patients with hilar hepatocarcinoma confirmed by pathology; 3.Under normal circumstances, radical surgery can be tolerated; 4.Not undergoing anti-tumor radiotherapy, chemotherapy and biological targeted therapy before surgery; 5.Able to comply with the plan during the research period and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.According to the judgment of the investigator, there are accompanying diseases that seriously endanger the safety of the patient or affect the completion of the study; 2.The expected survival period is less than 3 months; 3.Those who are unable or unwilling to comply with research requirements; 4.The patient is participating in other clinical trials at the same time; 5.Those who are deemed unsuitable to participate in this research after comprehensive judgment by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| R0 resection rate;1-year, 3-year, 5-year overall survival rate after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-year, 3-year, 5-year postoperative disease-free survival;Quality of life at 1 month, 6 months and 1 year after surgery (QLQ-C30 and BIL21 questionnaires);Surgical performance and disease burden (Economic evaluation); | — |
Countries
China
Contacts
Public ContactLi Jingdong
Affiliated Hospital of North Sichuan Medical College
Outcome results
None listed